Park Kyung Chan

USPTO Trademark & Patent Filings

Park Kyung Chan

Trademark applications and grants for Park Kyung Chan. Park Kyung Chan has 3 trademark applications. The latest application filed is for "TANGO ZENSUAL"

Company Profile
    Company Aliases
  • Chan Kyung Park
  • chan kyung park
  • PARK; Kyung Chan - Daejeon KR
  • Park; Kyung Chan - Daejeon KR
  • Park; Kyung Chan - Yuseong-gu KR
  • Park; Kyung Chan - Seoul KR

Trademarks Patents
Patent Applications
Patent ApplicationDate
METHOD FOR PREVENTING OR TREATING CANCER USING SYT11 INHIBITOR
20210361694 - 17/234455 CHEONG; Jae Ho ;   et al.
2021-11-25
Composition Containing Inhibitors of the Expression or Activity of SH3RF2 for Preventing or Treating Cancer
20120321635 - 13/574055 Park; Kyung Chan ;   et al.
2012-12-20
METHOD FOR DIAGNOSIS/PROGNOSIS OF CANCERS USING AN EPIGENETIC MARKER CONSISTING OF A SPECIFIC SINGLE CPG SITE IN TTP PROMOTER AND TREATMENT OF CANCERS BY REGULATING ITS EPIGENETIC STATUS
20120251499 - 13/514913 Yeom; Young Il ;   et al.
2012-10-04
HIGH-DENSITY RECORDING MEDIUM AND RECORDING AND/OR REPRODUCING DEVICE THEREFOR
20100014393 - 12/566500 KIM; Jin Yong ;   et al.
2010-01-21
High-density read-only optical disc, and optical disc apparatus and method using the same
20080056092 - 11/976387 Kim; Jin Yong ;   et al.
2008-03-06
CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer
9,075,066 - 12/679,879 Lee , et al. July 7, 2
2015-07-07
CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer
9,075,066 - 12/679,879 Lee , et al. July 7, 2
2015-07-07
Composition containing inhibitors of the expression or activity of SH3RF2 for preventing or treating cancer
8,809,295 - 13/574,055 Park , et al. August 19, 2
2014-08-19
Composition containing inhibitors of the expression or activity of SH3RF2 for preventing or treating cancer
8,809,295 - 13/574,055 Park , et al. August 19, 2
2014-08-19
Method for diagnosis/prognosis of cancers using an epigenetic marker consisting of a specific single CpG site in TTP promoter and treatment of cancers by regulating its epigenetic status
8,703,419 - 13/514,913 Yeom , et al. April 22, 2
2014-04-22
Patent Grants & Applications

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed